- $97.71m
- $88.85m
- $19.24m
- 31
- 13
- 85
- 39
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.84 | 7.58 | 13.9 | 15.6 | 19.2 |
Cost of Revenue | |||||
Gross Profit | 2.42 | 4.98 | 10.3 | 10.3 | 13.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 14.6 | 18.8 | 24.1 | 26.2 | 27.5 |
Operating Profit | -10.8 | -11.2 | -10.3 | -10.7 | -8.23 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.7 | -11.6 | -10.3 | -10.7 | -7.99 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.7 | -11.6 | -10.4 | -10.7 | -8.15 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.7 | -11.6 | -10.4 | -10.7 | -8.15 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11.5 | -12.2 | -11 | -10.7 | -8.15 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -20.8 | -3.46 | -1.89 | -1.52 | -0.276 |